PATENT CLAIM ANALYSIS

Application Number: 16048677
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["544", "106000"]

Abstract:
The present invention provides MDM2 inhibitor compounds of Formula I, or the pharmaceutically acceptable salts thereof, wherein the variables are defined above, which compounds are useful as therapeutic agents, particularly for the treatment of cancers. The present invention also relates to pharmaceutical compositions that contain an MDM2 inhibitor.

Claim (Index 16):
The compound of  claim 1  wherein R 4  is 4-chlorophenyl or 4-bromophenyl.

Metadata:
- Claim Count in Document: 55.0
- Percentile: 95.0
- Lexical Diversity: 1.35
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14347628', '15047523', '13308287', '12228421', '10131938']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8336387210128762
- 35 USC 102 Novelty (BERT): 0.5456242598327292
- Combined Prediction Score: 0.8048372748948615
- Mean Citation Score: 412.642012
- Max Citation Score: 422.45053
- Similarity Product: 312.9796647091854

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test